Literature DB >> 17826681

The application of human embryonic stem cell technologies to drug discovery.

Peter Sartipy1, Petter Björquist, Raimund Strehl, Johan Hyllner.   

Abstract

The isolation of human embryonic stem cells about a decade ago marked the birth of a new era in biomedical research. These pluripotent stem cells possess unique properties that make them exceptionally useful in a range of applications. Discussions about human stem cells are most often focused around the area of regenerative medicine and indeed, the possibility to apply these cells in cell replacement therapies is highly attractive. More imminent, however, is the employment of stem cell technologies for drug discovery and development. Novel improved in vitro models based on physiologically relevant human cells will result in better precision and more cost-effective assays ultimately leading to lower attrition rates and safe new drugs.

Entities:  

Mesh:

Year:  2007        PMID: 17826681     DOI: 10.1016/j.drudis.2007.07.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  22 in total

1.  Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells.

Authors:  Shulamit Levenberg; Lino S Ferreira; Limor Chen-Konak; Thomas P Kraehenbuehl; Robert Langer
Journal:  Nat Protoc       Date:  2010-05-27       Impact factor: 13.491

Review 2.  Cellular models for disease exploring and drug screening.

Authors:  Zhi-Kun Li; Qi Zhou
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

Review 3.  Human-induced pluripotent stem cells: in quest of clinical applications.

Authors:  Rosalinda Madonna
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

4.  Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells.

Authors:  Kartik Subramanian; Derek Jason Owens; Ravali Raju; Meri Firpo; Timothy D O'Brien; Catherine M Verfaillie; Wei-Shou Hu
Journal:  Stem Cells Dev       Date:  2013-10-22       Impact factor: 3.272

Review 5.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 6.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

Review 7.  Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System.

Authors:  Joshua G Hunsberger; Anastasia G Efthymiou; Nasir Malik; Mamta Behl; Ivy L Mead; Xianmin Zeng; Anton Simeonov; Mahendra Rao
Journal:  Stem Cells Dev       Date:  2015-04-20       Impact factor: 3.272

8.  Fabrication of a Multiplexed Artificial Cellular MicroEnvironment Array.

Authors:  Yasumasa Mashimo; Momoko Yoshioka; Yumie Tokunaga; Christopher Fockenberg; Shiho Terada; Yoshie Koyama; Teiko Shibata-Seki; Koki Yoshimoto; Risako Sakai; Hayase Hakariya; Li Liu; Toshihiro Akaike; Eiry Kobatake; Siew-Eng How; Motonari Uesugi; Yong Chen; Ken-Ichiro Kamei
Journal:  J Vis Exp       Date:  2018-09-07       Impact factor: 1.355

Review 9.  Stem cells and small molecule screening: haploid embryonic stem cells as a new tool.

Authors:  Bi Wu; Wei Li; Liu Wang; Zhong-hua Liu; Xiao-yang Zhao
Journal:  Acta Pharmacol Sin       Date:  2013-05-06       Impact factor: 6.150

10.  Characterisation of human embryonic stem cells conditioning media by 1H-nuclear magnetic resonance spectroscopy.

Authors:  David A MacIntyre; Darío Melguizo Sanchís; Beatriz Jiménez; Rubén Moreno; Miodrag Stojkovic; Antonio Pineda-Lucena
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.